0001587221-18-000023.txt : 20180601
0001587221-18-000023.hdr.sgml : 20180601
20180601185109
ACCESSION NUMBER: 0001587221-18-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180531
FILED AS OF DATE: 20180601
DATE AS OF CHANGE: 20180601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewis Hayley
CENTRAL INDEX KEY: 0001631295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36570
FILM NUMBER: 18876505
MAIL ADDRESS:
STREET 1: C/O CARBYLAN THERAPEUTICS, INC.
STREET 2: 3181 PORTER DRIVE
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zosano Pharma Corp
CENTRAL INDEX KEY: 0001587221
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454488360
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-1200
MAIL ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: ZP Holdings Inc
DATE OF NAME CHANGE: 20130919
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-05-31
0001587221
Zosano Pharma Corp
ZSAN
0001631295
Lewis Hayley
C/O ZOSANO PHARMA CORPORATION
34790 ARDENTECH COURT
FREMONT
CA
94555
0
1
0
0
Senior VP, Operations
Employee Stock Option (right to buy)
4.24
2018-05-31
4
A
0
100000
0
A
2028-04-16
Common Stock
100000
100000
D
The option grant was approved by the compensation committee of the Company's board of directors on April 16, 2018, subject to stockholder approval of an amendment to the stock option plan under which the option was granted. The Company's stockholders approved the plan amendment on May 31, 2018.
The shares underlying the stock option vest in equal monthly installments over a four-year period, beginning on May 16, 2018, so that all shares shall have vested on April 16, 2022.
/s/ Jeffrey L. Quillen, attorney-in-fact
2018-06-01